BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28594891)

  • 1. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.
    Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Muller V; Llosa AE; Uzzeni F; Luquero FJ; Ciglenecki I; Azman AS
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005652. PubMed ID: 28594891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L
    PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
    Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
    Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.
    Massing LA; Aboubakar S; Blake A; Page AL; Cohuet S; Ngandwe A; Mukomena Sompwe E; Ramazani R; Allheimen M; Levaillant P; Lechevalier P; Kashimi M; de la Motte A; Calmejane A; Bouhenia M; Dabire E; Bompangue D; Kebela B; Porten K; Luquero F
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006369. PubMed ID: 29734337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan.
    Porta MI; Lenglet A; de Weerdt S; Crestani R; Sinke R; Frawley MJ; Van Herp M; Zachariah R
    Trans R Soc Trop Med Hyg; 2014 Dec; 108(12):810-5. PubMed ID: 25311798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015.
    Lam E; Al-Tamimi W; Russell SP; Butt MO; Blanton C; Musani AS; Date K
    Emerg Infect Dis; 2017 Jan; 23(1):38-45. PubMed ID: 27983502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
    BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Lubogo M; Mohamed AM; Ali AH; Ali AH; Popal GR; Kiongo D; Bile KM; Malik M; Abubakar A
    Vaccine; 2020 Feb; 38 Suppl 1():A141-A147. PubMed ID: 31980193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.
    Azman AS; Luquero FJ; Ciglenecki I; Grais RF; Sack DA; Lessler J
    PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.
    Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Ciglenecki I; Luquero FJ; Azman AS; Cabrol JC
    Lancet Infect Dis; 2017 Apr; 17(4):e123-e127. PubMed ID: 28109819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.